Bioactive Compounds
-
B6599 ATPASummary: GluR5 kainate receptor agonist -
B6739 MDL 12330A hydrochlorideSummary: adenylate cyclase inhibitor -
B6801 SCH 79797 dihydrochlorideTarget: PARsSummary: PAR1 receptor antagonist -
B6925 Guggulsterone E&ZSummary: Broad spectrum steroid receptor ligand -
B7016 LOE 908 hydrochlorideSummary: Broad spectrum cation channel blocker -
B7074 (±)-AC 7954 hydrochlorideSummary: urotensin-II (UT) receptor agonist -
B7108 FexaramineSummary: farnesoid X receptor agonist -
B7127 PD 135158Summary: CCK2 receptor antagonist -
B7160 Zoniporide dihydrochlorideSummary: Sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor -
B7209 B2Summary: Promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease

